000 | 01584 a2200433 4500 | ||
---|---|---|---|
005 | 20250517013553.0 | ||
264 | 0 | _c20160629 | |
008 | 201606s 0 0 eng d | ||
022 | _a1473-1150 | ||
024 | 7 |
_a10.1038/tpj.2014.84 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMas, S | |
245 | 0 | 0 |
_aNetwork analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms. _h[electronic resource] |
260 |
_bThe pharmacogenomics journal _cOct 2015 |
||
300 |
_a452-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xgenetics |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 |
_aProtein Interaction Maps _xgenetics |
650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
650 | 0 | 4 |
_aRisperidone _xadministration & dosage |
650 | 0 | 4 |
_aSignal Transduction _xgenetics |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
700 | 1 | _aGassó, P | |
700 | 1 | _aParellada, E | |
700 | 1 | _aBernardo, M | |
700 | 1 | _aLafuente, A | |
773 | 0 |
_tThe pharmacogenomics journal _gvol. 15 _gno. 5 _gp. 452-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/tpj.2014.84 _zAvailable from publisher's website |
999 |
_c24567467 _d24567467 |